| #300 |
Amy L. Finkenaur |
Johnson & Johnson |
5 |
| #300 |
Ronald Perez |
Cornell University |
5 |
| #300 |
Felix Petz |
Agence Spatiale Europeenne |
5 |
| #300 |
Thomas Middleton |
Bby Solutions |
5 |
| #300 |
Motomitsu Adachi |
Fujitsu Limited |
5 |
| #300 |
David M. Del Giudice |
National Starch And Chemical Investment Holding Copporation |
5 |
| #300 |
Irving H. Neumann |
Butler Automatic |
5 |
| #300 |
Joseph Schwartz |
Pharmos |
5 |
| #300 |
Nikhiles Bandyopadhyay |
The Boc Group Limited |
5 |
| #300 |
Monica Tejwani-Motwani |
BOE |
5 |
| #300 |
Christos Christodoulatos |
Trustees Of The Stevens Institute Of Technology |
5 |
| #300 |
Michelle Cook |
Clariant Finance (Bvi) Limited |
5 |
| #300 |
Jeffrey A. Misiaszek |
Merck |
5 |
| #300 |
John W. Phalen |
Foster Wheeler Energy Limited |
5 |
| #300 |
Raghavendra Navath |
Wayne State University |
5 |
| #300 |
James Israel |
Ebi |
5 |
| #300 |
Danny Yu |
Biohaven Therapeutics |
5 |
| #300 |
Jack Donners |
Northwestern University |
5 |
| #300 |
Salman Parsi |
Siemens Hearing Instruments |
5 |
| #300 |
Yimsan Gau |
Union Carbide Chemicals & Plastics Technology |
5 |
| #300 |
Rocco Galante |
Pfizer |
5 |
| #300 |
Thomas S. Afferton |
AT&T |
5 |
| #300 |
Richard Chapman |
Schering |
5 |
| #300 |
Steve J. Nossen |
Alcatel Lucent |
5 |
| #300 |
Darrell R. Thompson |
Johnson & Johnson |
5 |
| #300 |
Norman W. Thomas |
Celanese Gmbh |
5 |
| #300 |
Ojas Prakashbhai Doshi |
Somerset Therapeutics |
5 |
| #300 |
Joseph B. McLean |
Hri |
5 |
| #300 |
Shuyi Chen |
Signum Biosciences |
5 |
| #300 |
William Patrick Gervasio |
Verizon |
5 |
| #300 |
Rajendra Padma Sadhu |
— |
5 |
| #300 |
Chun Huang |
Colgate-Palmolive |
5 |
| #300 |
Peter J. Lisi |
Ortho Diagnostic |
5 |
| #300 |
Linda Wright |
ExxonMobil |
5 |
| #300 |
Jeffrey M. Bessolo |
Wang Laboratories |
5 |
| #300 |
Subash Patel |
Novartis Ag |
5 |
| #300 |
Kenneth D. Rose |
ExxonMobil |
5 |
| #300 |
Eric Weisser |
National Starch And Chemical Investment Holding Copporation |
5 |
| #300 |
Shanthi Subramanian |
Triquint Technology Holding |
5 |
| #300 |
George E. Reier |
Fmc |
5 |
| #300 |
Kenyon E. B. McGuire |
Geovector |
5 |
| #300 |
Magda M. Gagliardi |
Merck |
5 |
| #300 |
James M. Fortunato |
Hoechst Roussel Pharmaceuticals |
5 |
| #300 |
Sethuraman Suresh |
Starfish Software |
5 |
| #300 |
James Alan Kerschen |
Elizabeth Arden |
5 |
| #300 |
John Tardy |
AT&T |
5 |
| #300 |
Elena Arvanitis |
Siemens Aktiengesellschaft |
5 |
| #300 |
Anthony Gegelys |
E.R. Squibb & Sons. |
5 |
| #300 |
Kevin Czaplinski |
Ptc Therapeutics |
5 |
| #300 |
Stanley E. Piechota, Jr. |
Colgate-Palmolive |
5 |